Experience

CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion

January 10, 2023

Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.

Read more

Related contacts

Rowook Park
Partner, San Diego
Rama Padmanabhan
Partner, San Diego
Div Gupta
Partner, New York
Sarah Sellers
Partner, New York
Christophe Beauduin
Special Counsel, New York
Benjamin “Izzy” Lubarsky
Associate, New York
Alessandra Murata
Partner, Palo Alto
Ajay Athavale
Associate, San Francisco
Megan Drill
Associate, San Diego
Melissa Meza
Associate, San Diego
Trey Reilly
Associate, New York
Amy Hallman Rice
Special Counsel, San Diego
Matthew D. Silverman
Special Counsel, San Diego
Howard Morse
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Rubin Waranch
Associate, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Charity Williams
Partner, San Diego
MaryBeth Shreiner
Associate, Reston
Elizabeth Lewis
Senior Counsel, Washington DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Patrick Sharma
Associate, Los Angeles Santa Monica
Karen Tsai
Special Counsel, Washington DC
Heidi A. Erlacher
Partner in Charge – Boston, Boston
Kristopher Kleiner
Special Counsel, Colorado
Ryan Sansom
Partner, Boston
Stephanie Gentile
Partner, New York
Aric Wu
Partner, New York
Christopher Kimball
Partner, Washington DC
Nyron J. Persaud
Partner, New York
Helenanne Connolly
Partner, Reston
Stella Sarma
Special Counsel, Brussels
Stella Sarma
Special Counsel, Brussels
Stacey A. Bradford
Special Counsel, Washington DC
Christine Graham
Special Counsel, London
Dillon Martinson
Special Counsel, Washington DC
Lindsey O'Crump
Associate, Washington DC
Vivian Tsai
Associate, Los Angeles Santa Monica
Arman Sagart
Associate, San Diego
Daniel Gillon
Associate, San Diego
Barry Kuang
Associate, Boston
Rajdeep Roger Bains
Associate, San Diego
Alexander Fullman
Associate, New York
Amanda Gonzalez Burton
Associate, New York
Grace Hunter
Associate, Washington DC
Kindall G. Jackson
Associate, Washington DC
Dr. Xixi Sun
Associate, Boston
Sarah Curry
Associate, New York
Carly Mitchell
Associate, Washington DC
Jennifer Shanley
Special Counsel, New York
Wyatt Kernell
Associate, New York
Allison Kutner
Associate, New York

Xometry – $287 Million Convertible Senior Notes Offering

February 24, 2022

Cooley advised Xometry on its offering of $287.5 million aggregate principal amount of 1% convertible senior notes due 2027. Partners Eric Blanchard, Mischi a Marca and Jason Savich led the Cooley team advising Xometry, which provides AI-enabled manufacturing equipment.

Related contacts

Eric Blanchard
Partner, New York
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Trey Reilly
Associate, New York
Nicholas Balenger
Associate, Reston

CS Disco – $246 Million IPO

July 21, 2021

Cooley advised CS Disco on its $246.4 million initial public offering of 7,700,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. CS Disco, whose securities now trade on the New York Stock Exchange under the symbol LAW, is the leading provider of software-as-a-service solutions developed by lawyers for lawyers. Partners Nicole Brookshire, Jodie Bourdet and Nicolas Dumont led the Cooley team.

Related contacts

Jodie Bourdet
Partner, San Francisco
Nicolas H.R. Dumont
Partner, New York
Trey Reilly
Associate, New York
Charles York
Associate, New York
Dennis F. Craig II
Associate, Washington DC

Xometry – $348 Million IPO

June 30, 2021

Cooley advised Xometry on its $347.9 million initial public offering of 7,906,250 shares of Class A common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Xometry, whose securities now trade on the Nasdaq Global Select Market under the symbol XMTR, is a leading AI-enabled marketplace for on-demand manufacturing. Partners Eric Blanchard, David Peinsipp, Mike Lincoln and Derek Colla led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
David Peinsipp
Partner, San Francisco
Mike Lincoln
Vice Chair, Reston
Derek Colla
Partner, Washington DC
Trey Reilly
Associate, New York
Dennis F. Craig II
Associate, Washington DC
Sarah Howard
Associate, Washington DC

Finch Therapeutics – $128 Million IPO

April 8, 2021

Cooley advised Finch Therapeutics on its $127.5 million initial public offering of 7,500,000 shares of common stock. Finch Therapeutics, whose securities now trade on the Nasdaq Global Select Market under the symbol FNCH, is a clinical-stage microbiome therapeutics company. Partners Div Gupta and Ryan Sansom led the Cooley team.

Related contacts

Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Courtney Thorne
Partner, Boston
Trey Reilly
Associate, New York
Michael Bruno
Associate, New York
Pengli Li
Associate, Boston
View more